New Type 2 drug shows promising trial results
A medication to treat Type 2 diabetes has significantly reduced blood sugar and body weight in participants of a late-phase clinical trial. Eli Lilly’s Tirzepatide is in
A medication to treat Type 2 diabetes has significantly reduced blood sugar and body weight in participants of a late-phase clinical trial. Eli Lilly’s Tirzepatide is in
Nemaura Medical has licenced a mobile app – Healthimation – to help with the prevention and management of Type 2 diabetes. Healthimation by LLC is
Diabetes UK is calling for increased funding for diabetes tech, so that more people living with diabetes can access the tech they need – and you
A Swansea University academic has helped draw up a landmark agreement among international experts, setting out the world’s first standard guidance on how people with
Insulet’s Omnipod Horizon AID (automated insulin delivery) is due to work with Abbott and Dexcom CGMs. Insulet’s partnerships with these two continuous glucose monitor companies
Eli Lilly, one of the Big Three insulin makers that’s had its eyes on diabetes technology for several years, is making moves to launch a
JDRF’s virtual Fusion event provided people living with Type 1 diabetes the possibility of accessing support and information on how to use medical technology to
A team of physicians from Baylor College of Medicine, Texas Children’s Hospital and the University of California, San Francisco, have announced the first case of a patient with
There’s plenty of broad coverage in this issue, with a lengthy look at the food sector with a round up of news from suppliers, proprietors
A new report states diabetes teams have learnt how to adapt to the ‘new normal’ amid Covid-19 but must re-engage with people who may feel